Loss of amphiregulin reduces myoepithelial cell coverage of mammary ducts and alters breast tumor growth-Reference-Cited by-同舟云学术

Loss of amphiregulin reduces myoepithelial cell coverage of mammary ducts and alters breast tumor growth

Published:2018-10-26 Issue:1 Volume:20 Page:
ISSN:1465-542X
Container-title:Breast Cancer Research
language:en
Short-container-title:Breast Cancer Res

Author:

Mao Serena P. H.,Park Minji,Cabrera Ramon M.,Christin John R.,Karagiannis George S.,Oktay Maja H.,Zaiss Dietmar M. W.,Abrams Scott I.,Guo Wenjun,Condeelis John S.,Kenny Paraic A.,Segall Jeffrey E.^ORCID

Funder

National Institutes of Health

Publisher

Springer Science and Business Media LLC

Link

http://link.springer.com/content/pdf/10.1186/s13058-018-1057-0.pdf

Reference56 articles.

1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68(1):7–30.

2. Sainsbury JR, et al. Epidermal-growth-factor receptor status as predictor of early recurrence of and death from breast cancer. Lancet. 1987;1(8547):1398–402.

3. Masuda H, et al. Role of epidermal growth factor receptor in breast cancer. Breast Cancer Res Treat. 2012;136(2):331–45.

4. Butti R, et al. Receptor tyrosine kinases (RTKs) in breast cancer: signaling, therapeutic implications and challenges. Mol Cancer. 2018;17(1):34.

5. Green MD, et al. Gefitinib treatment in hormone-resistant and hormone receptor-negative advanced breast cancer. Ann Oncol. 2009;20(11):1813–7.

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Purinergic signaling promotes premature senescence;Journal of Biological Chemistry;2024-04

2. Charting spatial ligand-target activity using Renoir;2023-04-17

3. Significance of Myoepithelial Cell Layer in Breast Ductal Carcinoma in situ With Papillary Architecture With and Without Associated Invasive Carcinoma;Clinical Breast Cancer;2023-01

4. Live-Cell Sender-Receiver Co-cultures for Quantitative Measurement of Paracrine Signaling Dynamics, Gene Expression, and Drug Response;Methods in Molecular Biology;2023

5. A recombinant affitoxin derived from a HER3 affibody and diphteria-toxin has potent and selective antitumor activity;International Journal of Biological Macromolecules;2022-10